Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HEROLD

Showing results (251-260 of 273) with videos related to

Pageof 28
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Diverse ancestry GWAS for advanced age-related macular degeneration in TOPMed-imputed and Ophthalmologically-confirmed 16,108 cases and 18,038 controlsMathias Gorski, Michelle Grunin, Janina M Herold, et al.
BMC Genomic Data|May 25, 2023
Polygenic scores for estimated glomerular filtration rate in a population of general adults and elderly - comparative results from the KORA and AugUR studyJanina M Herold, Jana Nano, Mathias Gorski, et al.
Investigative Ophthalmology & Visual Science|October 29, 2025
Diverse-Ancestry GWAS of Age-Related Macular Degeneration on 16,108 Examined Cases and 18,038 ControlsMathias Gorski, Michelle Grunin, Janina M Herold, et al.
Toxicology Letters|May 8, 2016
Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposureE Fabian, N Bordag, M Herold, et al.
Toxicology Letters|August 3, 2014
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasmaW Mattes, K Davis, E Fabian, et al.
Kidney International|July 31, 2024
Population-based reference values for kidney function and kidney function decline in 25- to 95-year-old Germans without and with diabetesJanina M Herold, Simon Wiegrebe, Jana Nano, et al.
Rheumatology (Oxford, England)|February 16, 2008
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologistsP I Sidiropoulos, G Hatemi, I-H Song, et al.
Lupus|June 3, 2016
Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015E K L Chan, J Damoiseaux, W de Melo Cruvinel, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2006
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)W Pönisch, P S Mitrou, K Merkle, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 28

Showing results (251-260 of 273) with videos related to

Sort By:
Pageof 28
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Diverse ancestry GWAS for advanced age-related macular degeneration in TOPMed-imputed and Ophthalmologically-confirmed 16,108 cases and 18,038 controlsMathias Gorski, Michelle Grunin, Janina M Herold, et al.
BMC Genomic Data|May 25, 2023
Polygenic scores for estimated glomerular filtration rate in a population of general adults and elderly - comparative results from the KORA and AugUR studyJanina M Herold, Jana Nano, Mathias Gorski, et al.
Investigative Ophthalmology & Visual Science|October 29, 2025
Diverse-Ancestry GWAS of Age-Related Macular Degeneration on 16,108 Examined Cases and 18,038 ControlsMathias Gorski, Michelle Grunin, Janina M Herold, et al.
Toxicology Letters|May 8, 2016
Metabolite profiles of rats in repeated dose toxicological studies after oral and inhalative exposureE Fabian, N Bordag, M Herold, et al.
Toxicology Letters|August 3, 2014
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasmaW Mattes, K Davis, E Fabian, et al.
Kidney International|July 31, 2024
Population-based reference values for kidney function and kidney function decline in 25- to 95-year-old Germans without and with diabetesJanina M Herold, Simon Wiegrebe, Jana Nano, et al.
Rheumatology (Oxford, England)|February 16, 2008
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologistsP I Sidiropoulos, G Hatemi, I-H Song, et al.
Lupus|June 3, 2016
Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015E K L Chan, J Damoiseaux, W de Melo Cruvinel, et al.
Journal of Cancer Research and Clinical Oncology|January 13, 2006
Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)W Pönisch, P S Mitrou, K Merkle, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 28